Loading...
Eurofins Scientific SE
ERF.PA•EURONEXT
Healthcare
Medical - Diagnostics & Research
€63.36
€1.78(2.89%)
Eurofins Scientific SE (ERF.PA) Financial Performance & Statements
Review Eurofins Scientific SE’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.70%
↑ 6.70%
Operating Income Growth
32.81%
↑ 32.81%
Net Income Growth
30.97%
↑ 30.97%
Operating Cash Flow Growth
29.57%
↑ 29.57%
Operating Margin
10.45%
↑ 10.45%
Gross Margin
10.45%
↑ 10.45%
Net Profit Margin
4.07%
↑ 4.07%
ROE
5.34%
↑ 5.34%
ROIC
8.27%
↑ 8.27%
Eurofins Scientific SE (ERF.PA) Financial Statements
Explore quarterly and annual reports for Eurofins Scientific SE stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $3.53B | $3.42B | $3.31B | $1.65B |
| Cost of Revenue | $3.18B | $3.04B | $3.03B | $1.28B |
| Gross Profit | $351.70M | $374.50M | $279.90M | $367.55M |
| Gross Profit Ratio | $0.10 | $0.11 | $0.08 | $0.22 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $57.60M | $37.75M | $37.75M |
| Operating Expenses | $0.00 | $57.60M | $232.65M | $232.65M |
| Total Costs & Expenses | -$3.18B | $2.72B | $3.03B | $1.52B |
| Interest Income | $0.00 | $15.00M | $0.00 | $33.05M |
| Interest Expense | $69.10M | $84.00M | $63.70M | $0.00 |
| Depreciation & Amortization | $362.20M | $329.20M | $353.60M | $86.85M |
| EBITDA | $684.50M | $702.20M | $620.90M | $277.15M |
| EBITDA Ratio | $0.19 | $0.21 | $0.19 | $0.17 |
| Operating Income | $351.70M | $374.50M | $279.90M | $190.30M |
| Operating Income Ratio | $0.10 | $0.11 | $0.08 | $0.12 |
| Other Income/Expenses (Net) | -$98.50M | -$74.10M | -$76.30M | -$88.45M |
| Income Before Tax | $253.20M | $300.40M | $203.60M | $101.85M |
| Income Before Tax Ratio | $0.07 | $0.09 | $0.06 | $0.06 |
| Income Tax Expense | $67.70M | $81.40M | $46.60M | $23.30M |
| Net Income | $185.70M | $97.05M | $158.80M | $65.90M |
| Net Income Ratio | $0.05 | $0.03 | $0.05 | $0.04 |
| EPS | $0.99 | $1.14 | $0.83 | $0.34 |
| Diluted EPS | $0.96 | $1.13 | $0.80 | $0.33 |
| Weighted Avg Shares Outstanding | $187.82M | $193.00M | $192.03M | $196.70M |
| Weighted Avg Shares Outstanding (Diluted) | $193.67M | $195.20M | $197.61M | $197.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan